Cleveland Clinic researchers have performed the first comprehensive immunoprofiling study of patients with severe fever with thrombocytopenia syndrome (SFTS), an emerging tick-borne disease.
Advancing Immunotherapy: A Conversation with Timothy Chan, MD, PhD
Timothy Chan, MD, PhD, the renowned cancer researcher who directs Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology, plans to use genomic analysis and high-throughput immunoprofiling to develop advanced targeted therapies.